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INTRODUCTION
The ongoing pandemic caused by severe 
acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) has affected over 200 million 
people worldwide with at least 4.4 million 
deaths owing to COVID-19 as of August 
2021.1 The need to direct resources towards 
patients requiring treatment for COVID-19 
and to minimise opportunities for spread 
by reducing face-to-face contact between 
individuals meant that routine healthcare 
services faced significant levels of disruption. 
Shortly after declaring COVID-19 a public 
health emergency of international concern, 
the World Health Organization (WHO) 
reiterated their operational preparedness 
guidance. The intention of the guidance was 
to provide countries with advice on how to 
minimise direct and indirect mortality from 
COVID-19 through the continued provision 
of essential services. Recommendations 
included rapid assessment of healthcare 
capacity and the development of key 
performance metrics, and also highlighted 
the importance of keeping this data up to 
date.2,3 The NHS in England responded to 
the emerging pandemic by stopping non-
urgent work in hospitals, and suggesting 
that, where possible, patients should have 
non-urgent primary care appointments 
remotely.4 
In a rapid assessment conducted in 
May 2020, WHO found that across the 
world there has been a considerable 
impact on the treatment of people with 
non-communicable disease (NCDs, non-
infectious diseases not passed from person 
to person) caused by severe disruption to 
the delivery of national healthcare services.5 
Subsequently, NHS England issued 
guidance on the ‘third phase’ of the NHS 
response to COVID-19 on 21 July 2020. 
One of the many recommendations was to 
restore NHS services to near-normal levels 
where clinically appropriate before winter, 
while remaining vigilant for a second wave.6 
OpenSAFELY is a new secure analytics 
platform for electronic patient records built by 
the author group on behalf of NHS England 
to deliver urgent academic and operational 
Abstract
Background
The COVID-19 pandemic has disrupted 
healthcare activity. The NHS stopped non-urgent 
work in March 2020, later recommending 
services be restored to near-normal levels before 
winter where possible. 
Aim
To describe the volume and variation of coded 
clinical activity in general practice, taking 
respiratory disease and laboratory procedures as 
examples.
Design and setting
Working on behalf of NHS England, a cohort 
study was conducted of 23.8 million patient 
records in general practice, in situ using 
OpenSAFELY.
Method
Activity using Clinical Terms Version 3 codes 
and keyword searches from January 2019 to 
September 2020 are described.
Results
Activity recorded in general practice declined 
during the pandemic, but largely recovered by 
September. There was a large drop in coded 
activity for laboratory tests, with broad recovery 
to pre-pandemic levels by September. One 
exception was the international normalised ratio 
test, with a smaller reduction (median tests per 
1000 patients in 2020: February 8.0; April 6.2; 
September 6.9). The pattern of recording for 
respiratory symptoms was less affected, following 
an expected seasonal pattern and classified as 
‘no change’. Respiratory infections exhibited a 
sustained drop, not returning to pre-pandemic 
levels by September. Asthma reviews experienced 
a small drop but recovered, whereas chronic 
obstructive pulmonary disease reviews remained 
below baseline.
Conclusion
An open-source software framework was 
delivered to describe trends and variation in 
clinical activity across an unprecedented scale of 
primary care data. The COVD-19 pandemic led to 
a substantial change in healthcare activity. Most 
laboratory tests showed substantial reduction, 
largely recovering to near-normal levels by 
September, with some important tests less 
affected and recording of respiratory disease 
codes was mixed.
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research during the pandemic:7 analyses can 
currently run across all patients’ full raw 
pseudonymised primary care records at 40% 
of English general practices, with patient-
level linkage to various sources of secondary 
care data; all code and analysis is shared 
openly for inspection and re-use. A stated 
aim of OpenSAFELY is to assess ‘COVID 
aftershocks’ where data are monitored to 
measure and mitigate the indirect health 
impact of COVID-19.8 In order to produce 
the best possible insights across a range 
of diverse topics using this huge volume of 
activity and data, this author group is working 
with NHS England to create a programme 
of work that is called the OpenSAFELY NHS 
Service Restoration Observatory.
Traditionally researchers using electronic 
health records (EHRs) data create bespoke 
manually curated ‘codelists’ to identify 
certain diseases or units of healthcare 
activity. However, as the scale of raw data 
is unprecedented, a data-driven approach 
is initially being deployed utilising natural 
hierarchies contained within Clinical 
Terms Version 3 (CTV3) code structures 
(Box 1). The insights generated will then be 
manually reviewed and prioritised by groups 
of clinicians and commissioners for further 
analysis. The aim is to rapidly identify all 
important changes in clinical practice that 
have been collaboratively determined by 
clinicians and commissioners to be of high 
clinical importance, and then prioritise each 
relevant activity change for either remedial 
activity, additional monitoring, feedback to 
practices and regions, or further exploration. 
In this article the first phase of this work 
is set out, describing trends and variation 
in clinical activity codes to evaluate NHS 
service restoration from the first wave of 
the pandemic in England. Two large clinical 
topic areas were pragmatically selected 
for this first phase of work: ‘respiratory 
disease’, because this encompasses 
infectious diseases and common NCDs 
such as asthma and chronic obstructive 
pulmonary disease (COPD); and ‘laboratory 
procedures’ including blood tests, because 
these are required in diagnosis and 
monitoring for a broad range of NCDs. A 
classification system was also developed 




General practice clinical activity was 
described by conducting a retrospective 
cohort study using raw data from English 
NHS general practices.
Data source
Primary care records managed by TPP 
were analysed through OpenSAFELY, a data 
analytics platform created by the author 
team on behalf of NHS England to address 
urgent COVID-19 research questions 
(https://opensafely.org). OpenSAFELY 
provides a secure software interface 
allowing researchers to run statistical 
analysis code across pseudonymised 
primary care patient records from England 
in near real time within the EHR vendor’s 
highly secure data centre, avoiding the 
need for large volumes of potentially 
disclosive pseudonymised patient data to 
be transferred off-site. This, in addition to 
other technical and organisational controls, 
minimises any risk of re-identification. 
Pseudonymised datasets from other data 
providers are securely provided to the EHR 
vendor and linked to the primary care data. 
British Journal of General Practice, Online First 2021  2
How this fits in 
During the COVID-19 pandemic, routine 
healthcare services in England faced 
significant levels of disruption, and NHS 
England recommended restoring NHS 
services to near-normal levels before 
the winter of 2020. This study found that, 
compared with activity in 2019, many 
pathology tests and much respiratory 
activity in primary care saw significant 
activity reductions from April to September 
2020, largely recovering to near-normal 
levels by September, and some important 
tests were maintained at near-normal 
levels throughout. The authors are further 
developing the OpenSAFELY NHS Service 
Restoration Observatory for real-time 
monitoring and feedback for frontline 
clinicians and managers, to help measure 
and mitigate the ongoing indirect impact of 
COVID-19 on health and the NHS.
Box 1. Clinical Terms Version 3 (CTV3) codes
• CTV3 is a comprehensive computerised coding dictionary used by clinicians to record key clinical 
information about patients and also associated tests, diagnosis, and medicines. 
• CTV3 codes are used in the OpenSAFELY-TPP implementation, and fully align with the GP subset of 
SNOMED CT, the NHS standard.9 
• There are almost 300 000 codes in total, each five characters long. 
• CTV3 codes can be organised into hierarchies much like a book with chapters. CTV3 has a tree data 
structure with ‘parent’ concepts describing broader clinical areas and ‘child’ codes of increasing specificity 
as you move down the hierarchy. 
• For example, a concept such as ‘laboratory procedures’ will have ‘child’ codes that are more specific such 
as ‘haematology’, which will in turn be broken down further into increasingly detailed concepts. 
• Most child codes can only have a single parent, although 3% have multiple parents.
The dataset contains information on 
23.8 million people registered with GP 
surgeries using TPP SystmOne software 
at 30 September 2020. It includes 
pseudonymised data such as coded 
diagnoses, medications, and physiological 
parameters; no free-text data are included. 
Practices are identified by pseudonymised 
codes only. Further details on information 
governance can be found in Supplementary 
Appendix S1. 
Study population
All patients registered with any practice 
using TPP EHR software (those who were 
registered as of 30 September 2020) were 
included. All coded events between January 
2019 and the end of September 2020 for this 
cohort were included. Coded events cover 
clinical diagnoses, symptoms, observations, 
investigations, administrative activities, and 
other information recorded about patients. 
Codes may be manually entered by GPs/
nurses or other practice staff, generated 
automatically when certain activities are 
carried out such as completing forms or 
templates, or derived from external sources 
such as secondary care.
Data processing 
Data was grouped at the practice level. Each 
patient’s latest practice (as at 30 September 
2020) was used as their assigned practice 
for all activity throughout the study period. 
A data-driven approach was employed to 
capture the most common coded events in 
primary care. Codes were ranked according 
to the number of total occurrences in 
January to September 2020, excluding 
those codes with <1000 occurrences. 
The total population in each practice was 
calculated as the total registered patients 
at 30 September 2020 and the same value 
used for every month.
Clinical code classification 
EHR systems in UK primary care have 
historically used a number of different 
clinical terminologies, including Read 
codes Version 2 (V2) and the CTV3 
(Box 1). Following the issue of a recent 
NHS standard, all primary care systems 
must now be compliant with SNOMED 
CT.9 More specifically, GP systems use 
a specific reference subset of the whole 
SNOMED CT terminology, known as the ‘GP 
subset’. This subset very closely mirrors 
CTV3, the terminology historically used by 
TPP systems. There is a comprehensive, 
accurate mapping table between CTV3 
and the UK ‘GP subset’ of SNOMED CT. 
Users of TPP GP EHR software default 
to work in SNOMED CT, but can choose 
to view records and browse codes using 
CTV3, to facilitate their transition to the 
new terminology. For the OpenSAFELY-TPP 
analysis here, the authors have worked 
within the CTV3 framework, to work rapidly 
and utilise its hierarchy structures.
CTV3 codes often give great detail on 
specific clinical findings or diagnoses. The 
authors of this current study therefore 
classified codes into a number of groups 
to ascertain more general trends. This was 
achieved in two ways. First, CTV3 supports 
a comprehensive parent–child concept 
hierarchy, with defined relationships 
between different clinical concepts (Box 1). 
The authors have utilised this hierarchy to 
support the classification of codes into high-
level groups. Second, these groups were 
supplemented using the broad historical 
‘category’ structure of older terminologies, 
where parent–child relationships can be 
ascertained by a common set of initial 
characters. The authors acknowledge that 
this second approach can produce a small 
number of inappropriate or missing codes. 
It has, however, made it possible to work 
very rapidly to identify general trends. This 
is discussed further in the ‘Strengths and 
limitations’ section of this article.
As an example, individual CTV3 codes 
were grouped into high-level topics 
using their first two digits, for example, 
42, ‘haematology’. Second, codes were 
grouped by their first three digits to give 
a further breakdown of activities (for 
example, 42Q, ‘blood coagulation test’). 
Although this approach generally produces 
logical groupings, there may be some 
examples where this is not the case, for 
example, ‘asthma’ (H33...) is grouped under 
‘chronic obstructive lung disease’ (H3...), 
now considered an outdated classification. 
Further, these groups are non-exhaustive, 
because some codes related to these topics 
do not fall under this natural hierarchy; 
these ungrouped CTV3 codes (most 
commonly beginning with ‘X’ or ‘Y’) are 
therefore presented individually. 
Code selection 
Codes and groups were mapped to high-
level ‘concepts’ (Box 1) to assist with 
categorising them into related topics. 
Codes were selected for each topic using 
concepts and/or keyword searches of code 
descriptions. For each topic up to 75 of 
the most commonly occurring codes were 
selected.
• Pathology: codes were identified under 
the following concepts: ‘laboratory 
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procedures’ (‘4....’), ‘laboratory 
test’ (‘X7A0B’), and ‘laboratory test 
observations’ (‘X76sW’).
• Respiratory: codes were identified based 
on the keywords ‘respiratory’, ‘asthma’, 
‘COPD’, ‘chronic obstructive’, and 
‘inhaler’. Keywords related to COVID-19 
were not specifically included, so it is 
likely that some but not all COVID-19 
codes will be captured.
Missing data
Missing data may arise through lack of 
inclusion of patients who have died; but this 
is likely to only have a limited impact on 
most codes, except in those used for end-of-
life issues that are relatively rare. Patients 
who have moved away from TPP practices 
were not included but those who moved into 
their latest practice during the study period 
were included. Certain codes may appear 
to have missing data owing to variable 
code use between practices, through, for 
example, selection of valid alternatives, use 
of different tools or templates, differing 
practice administrative processes, or use of 
on-screen tools for which codes do not get 
recorded. The authors could not account for 
these but expect that they will be generally 
consistent within each practice over time. 
Study measures
The monthly incidence of each code 
(or group of codes) per 1000 registered 
patients at each practice was calculated. 
The median and deciles across all practices 
each month for each code were calculated, 
after excluding practices that never used 
that code in the study period. Time trend 
charts are used to present data. All charts 
were collaboratively reviewed by clinicians 
and researchers; selected charts are shown 
in the ‘Results’ section to illustrate key 
patterns, with additional selected charts in 
Supplementary Appendix S2, and all charts 
are provided in the associated OpenSAFELY 
GitHub repository.10 
In the case of all grouped (‘parent’) 
codes, a table of the top (up to) five ‘child’ 
codes is presented to illustrate examples of 
individual codes captured, and time trends 
of the top most common code have been 
plotted. Fewer than five child codes being 
shown indicates that fewer than five codes 
exist in the group, or fewer than five reached 
the 1000 minimum 2020 activity threshold.
Classification of service restoration
With each chart the median value and 
interdecile range (IDR) for February, 
April, and September 2020 are displayed. 
February was selected as the last full month 
before lockdown measures were instigated 
in March, whereas April was identified as 
the first full month after full lockdown. 
September was the latest full month at the 
time of initiating this analysis and before the 
‘second wave’ of infections would have been 
expected to influence health services once 
again. To aid interpretation, an approximate 
classification based on changes to the 
median compared with the same month 
the previous year is provided, which is 
defined as the study ‘baseline’ (Box 2).
Software and reproducibility
Data management was performed using 
Python and the OpenSAFELY software, with 
data extracted via SQL Server Management 
Studio and analysis carried out using Python. 
All of the code used for data management 
and analyses is openly shared online for 
review and re-use (https://github.com/
opensafely/restoration-observatory-intro-
notebook). 
Patient and public involvement
This analysis relies on the use of large 
volumes of patient data. Ensuring patient, 
professional, and public trust is therefore 
of critical importance. Maintaining trust 
requires being transparent about the way 
OpenSAFELY works, and ensuring patient 
voices are represented in the design 
of research, analysis of the findings, 
and considering the implications. For 
transparency purposes a public website 
has been developed that provides a detailed 
description of the platform in language 
suitable for a lay audience; the authors will 
be co-developing an explainer video; and 
have presented at a number of online public 
engagement events to key communities. 
To ensure the patient voice is represented, 
Box 2. Service change classification
1. For April and September:
 • no change: activity remained within 15% of the baseline level;
 • increase: an increase of >15% from baseline;
 • small drop: a reduction of between 15% and 60% from baseline;
 • large drop: a reduction of >60% from baseline.
2. Overall classification:
 • no change: no change in both April and September;
 • increase: an increase in either April or September;
 •  sustained drop: a small or large drop in April, which has not returned to within 15% of baseline by 
September 2020;
 •  recovery: a small or large drop in April, which returned to within 15% of baseline (‘no change’) by 
September 2020.
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the authors are working closely with 
appropriate medical research charities. In 
this instance, the draft paper has been 
shared with the Association of Medical 
Research Charities for general comment 
via a webinar and online feedback form, 
and specifically to Asthma UK and the 
British Lung Foundation for feedback from 
the perspective of those most affected by 
these findings, before publication in a peer-
reviewed journal. 
RESULTS
This study included 23 878 341 registered 
patients across 2546 practices. Between 
38.8% and 100% of practices were 
represented in each chart. From January to 
September 2020 for laboratory procedures 
83.6 million recorded events grouped under 
two-digit ‘parent’ codes were identified, and 
235.7 million events grouped at three digits 
where possible, or at the full code level. 
By comparison, for respiratory disease 
1.4 million events at the two-digit parent 
code level were identified, and 22.3 million 
events grouped at three digits where 
possible, or at the full code level. All charts 
are shown in the associated OpenSAFELY 
GitHub repository, with selected highlights 
shown in the figures and in Supplementary 
Appendix S2.
Pathology
Most two-digit high-level codes showed a 
similar pattern — a large drop (Box 2) in 
activity in April 2020, recovering to normal 
levels over the summer. A representative 
example, haematology laboratory tests 
activity, is shown in Figure 1. The variation 
observed between practices in September 
(IDR 280.7) was similar to before the 
pandemic in February (IDR 276.8). More 
broadly, many individual tests had similar 
large drops in activity in April followed 
by substantial recovery, such as liver 
function, serum alkaline phosphate, serum 
creatinine, and serum potassium (see 
Supplementary Appendix S2). 
The largest drop was observed in 
‘serum cholesterol (& level)’ (Figure 2a) 
with the median falling by 90.2% from 
the previous year to 2.9 tests per 1000 in 
April. This recovered to near-normal levels 
by September, with the variation between 
practices similar to that seen in February 
(IDR 45.5 in both months). In contrast, blood 
coagulation tests such as the international 
normalised ratio (INR), used to support 
management of anticoagulation, showed 
only a small drop in April (median 6.2/1000) 
compared with the pre-pandemic level 
(median 8.0/1000; Figure 2b).
Respiratory disease
The codes under respiratory disease can 
be broadly divided into those relating to 
symptoms and acute infections, and those 
relating to long-term conditions. 
Symptoms and acute infections. Recording 
of codes grouped under ‘respiratory 
symptoms’ remained relatively stable 
throughout the observed period (Figure 3), 
largely following an expected seasonal 
pattern. Three individual codes were 
selected that demonstrate broad patterns 
in the recording of acute respiratory 
infections (Figure 4). ‘Viral upper respiratory 
tract infection’ (‘Xa1sb’) exhibited a large 
and sustained drop compared with pre-
pandemic levels, remaining substantially 
lower than in the previous year (September 
–80.4%, Figure 4a). Similarly, ‘infection of 
lower respiratory tract’ (‘X1004’) experienced 
a large drop (April –77.2%, Figure 4b). 
As the recording of other respiratory 
infections began to drop, ‘Suspected 
coronavirus disease 19 caused by severe 
acute respiratory syndrome coronavirus 
2’ (‘Y20cf’) increased rapidly during spring 
(April median 3.7/1000, IDR 6.8, Figure 4c; 
‘42’ — Haematology
(Practices included: 2.5k [100.0%]; 2020 patients: 4.42m; 2020 events: 65.66m)
February median: 378.9 (IDR 276.8), April median: 101.1 (IDR 138.3), September median: 347.6 (IDR 280.7)
Change in median from 2019: April –71.8% (Large drop); September –6.3% (No change);
Overall classification: Recovered
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Mean cell volume
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Eosinophil count — observation
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Figure 1. Recording of codes grouped under 
‘haematology’ across TPP practices in England 
(January 2019 to September 2020). The group includes 
CTV3 codes that begin with ‘42’ and is not necessarily 
an exhaustive collection of every activity related to 
haematology. The top five codes represented within this 
group are listed under the graph.
CTV3 = Clinical Terms Version 3. IDR = interdecile 
range. k = thousand. m = million.
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other codes related to COVID-19 can be 
found in Supplementary Appendix S2). 
This then decreased dramatically over 
the summer before increasing again in 
September (median 1.7/1000, IDR 2.8).
Long-term respiratory conditions. Codes 
for both ‘asthma’ and ‘chronic obstructive 
lung disease’ were included within the 
high-level group of codes beginning ‘H3’, 
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Serum LDL cholesterol level
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2020 events (k) Description



















Thrombin time — observation
INR — international normal ratio normal
INR — international normal ratio abnormal
2020 events (k) Description
‘44P’ — Serum cholesterol (& level)
(Practices included: 2.5k [100.0%]; 2020 patients: 2.71m; 2020 events: 5.03m)
February median: 32.6 (IDR 45.5), April median: 2.9 (IDR 7.2), September median: 27.4 (IDR 45.5)
Change in median from 2019: April –90.2% (Large drop); September –11.0% (No change);
Overall classification: Recovered
a)
‘42Q’ — Blood coagulation test
(Practices included: 2.5k [99.9%]; 2020 patients: 297.6k; 2020 events: 1.96m)
Feb median: 8.0 (IDR 17.3), April median: 6.2 (IDR 15.4), September median: 6.9 (IDR 16.7)
Change in median from 2019: April –32.8% (Small drop); September –19.6% (Small drop);
Overall classification: Sustained drop
b)
Figure 2. Recording of grouped subsets of pathology 
codes across TPP practices in England (January 2019 
to September 2020). a) ‘Serum cholesterol (& level)’. 
The group includes CTV3 codes that begin with ‘44P’ 
and is not necessarily an exhaustive collection of every 
activity related to serum cholesterol testing. b) ‘Blood 
coagulation test’. The group includes CTV3 codes that 
begin with ‘42Q’ and is not necessarily an exhaustive 
collection of every activity related to blood coagulation 
testing. The top five codes represented within this 
group are listed under the graph. CTV3 = Clinical 
Terms Version 3. HDL = high-density lipoprotein. 
IDR = interdecile range. INR = international normalised 
ratio. k = thousand. LDL = low-density lipoprotein. 
m = million. 
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260 000 codes were recorded in 2020 by 
99.8% (n = 2500) of practices (Figure 5). 
Overall, this group showed a small drop 
in April (median 0.5/1000, –49.0%) with 
some recovery by September (median 
0.7/1000, –35.7% compared with the 
previous September). There were similar 
trends in some individual codes related 
to monitoring of these conditions, such 
as ‘chronic obstructive pulmonary disease 
annual review’ (‘Xalet’, Figure 6a), with a 
large drop followed by partial recovery (April 
–66.7%, September –36.1%). Following a 
broadly similar pattern, ‘asthma annual 
review’ (‘Xaleq’, Figure 6b) exhibited a 
smaller drop (April median 2.8/1000, 
–29.3% from the previous April) but with 
widening variation (IDR 10.6, compared with 
7.8 in February with median 5.1/1000). This 
code had a more complete recovery, to 
a median of 3.8 in September (–11.8% 
from the previous September), but with 
wide variation persisting (IDR 8.4). Several 
other codes related to asthma monitoring 
had a gradually increasing pattern, with a 
dramatic increase in September, including 
‘asthma control test‘ (‘XaQHq’, Figure 6c), 
‘number of asthma exacerbations in past 
year’ (‘XaINh’; Supplementary Appendix S2), 
and ‘asthma self-management plan review’ 
(‘XaYZB’; Supplementary Appendix S2). 
‘Asthma control test’, previously a relatively 
unusual code but with high variation 
(February median 0.8/1000, IDR 7.4), rose 
sharply in September to a median of 
2.8/1000 (IDR 10.2, Figure 6c).
DISCUSSION
Summary
It was possible to successfully generate data 
on trends and variation in clinical activity 
across the records of 40% of all practices 
in England. Substantial and widespread 
changes in the pattern of clinical activity 
for laboratory procedures and respiratory 
disease in primary care since the onset of 
the COVID-19 pandemic were identified. 
Broadly, clinical activity related to laboratory 
procedures such as blood tests declined 
substantially after ‘lockdown’ but recovered 
quickly over the summer. Blood tests to 
manage high-risk anticoagulants, however, 
were prioritised and did not experience 
a similar drop off in activity. Recording 
of respiratory symptoms overall, including 
cough and breathlessness, remained 
relatively constant, although codes related 
to viral respiratory illness substantially 
declined compared with previous activity, 
with the exception of those specifically 
related to COVID-19. A small decline was 
observed associated with high-level codes 
for long-term respiratory conditions such 
as COPD and asthma. Activity related to 
asthma annual reviews experienced a small 
drop but has since recovered, whereas 
COPD annual reviews are still below 
baseline. 
Strengths and limitations
The key strengths of this study are the 
scale and completeness of the underlying 
raw EHR data. The OpenSAFELY platform 
runs analyses across an unprecedented 
scale of data — the full dataset of all 
raw, single-event-level clinical events for 
all patients at 40% of all GP practices in 
England, including all tests, treatments, 
diagnostic events, and other salient 
clinical and demographic information 
for 23.8 million patients. By contrast the 
Clinical Practice Research Datalink (CPRD) 
dataset contains records for a substantially 
smaller number of current patients spread 
across two databases; and the General 
Practice Extraction Service dataset held 
by NHS Digital contains a much smaller 
amount of data on each individual patient. 
OpenSAFELY also provides data in near 
real time, providing unprecedented 
opportunities for audit and feedback to 

























































‘17’ — Respiratory symptoms
(Practices included: 2.5k [100.0%]; 2020 events: 0.92m); 2020 patients: 668.7k
February median: 3.6 (IDR 11.9), April median: 2.0 (IDR 7.0), September median: 2.4 (IDR 8.7)
Change in median from 2019: April –8.2% (No change); September –4.1% (No change);
Overall classification: No change
decile
median






















2020 events (k) Description
Figure 3. Recording of codes grouped under 
‘respiratory symptoms’ across TPP practices in 
England (January 2019 to September 2020). The group 
includes CTV3 codes that begin with ‘17’ and is not 
necessarily an exhaustive collection of every activity 
related to respiratory symptoms. The top five codes 
represented within this group are listed under the 
graph.
CTV3 = Clinical Terms Version 3. IDR = interdecile 
range. k = thousand. m = million. 
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health service activity — the delay from 
occurrence of a clinical event to it appearing 
in the OpenSAFELY platform varies from 
2–9 days. This is substantially faster than 
any other source of GP data, including 
those giving much less complete records. 
It is also faster than any source of large-
scale secondary care data as the Secondary 
Figure 4. Recording of selected individual codes 
related to respiratory infections across TPP practices 
in England (January 2019 to September 2020). a) Viral 
upper respiratory tract infection, b) infection of lower 
respiratory tract, and c) suspected COVID-19. These 
were the most common codes identified for these 
activities, but other codes may also be used to record 
the same or similar activities. 
DR = interdecile range. k = thousand. m = million. 
a) ‘Xa1sb’ — Viral upper respiratory tract infection
(Practices included: 2.5k [99.8%]; 2020 events: 0.29m); 2020 patients: 273.7k
February median: 3.3 (IDR 6.9), April median: 0.1 (IDR 0.6), September median: 0.4 (IDR 1.5)
Change in median from 2019: April –94.9% (Large drop); September –80.4% (Large drop); 
Overall classification: Sustained drop
b) ‘X1004’ — Infection of lower respiratory tract
(Practices included: 2.5k [99.6%]; 2020 events: 0.18m); 2020 patients: 161.6k
February median: 1.3 (IDR 3.3), April median: 0.2 (IDR 0.9), September median: 0.3 (IDR 1.1)
Change in median from 2019: April –77.2% (Large drop); September –61.9% (Large drop); 
Overall classification: Sustained drop
c) ‘Y20cf’ — Suspected coronavirus disease 19 caused by severe acute respiratory syndrome
coronavirus 2 (situation)
(Practices included: 2.5k [99.6%]; 2020 events: 0.31m); 2020 patients: 245.2k
February median: 0.0 (IDR 0.1), April median: 3.7 (IDR 6.8), September median: 1.7 (IDR 2.8)
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Users Service dataset, containing duration 
and main activity for each hospital event, is 
coded several weeks after completion (not 
commencement) of the clinical episode or 
spell.
Some limitations are also recognised. A 
data-driven approach was used, capitalising 
on the historical CTV3 hierarchy where 
possible, in combination with the CTV3 
concept hierarchy. There may be other 
codes relevant to laboratory procedures 
and respiratory conditions that have been 
omitted; the authors intend to iterate the 
approach used with manual curation of 
‘codelists’ and utilisation of SNOMED CT 
hierarchies to better understand activity. 
With the exception of a small amount 
of legally restricted data, all occurrences 
of codes are included, and they do not 
necessarily indicate unique or new events, 
for example, one patient encounter could 
generate several similar codes, one patient 
might have similar diagnoses recorded on 
multiple occasions over time, or practices 
might bulk-import information. Coding 
activity was studied and some apparent 
changes may represent changes in coding 
behaviour. The large population covered 
here is likely to be broadly representative 
of the whole of England’s population, but 
some coding practices may vary between 
different EHR systems, so not all of these 
findings will be generalisable. 
Finally, codes were counted against 
patients, who were then allocated to their 
latest registered practice as at the end 
of the study period. All patients with an 
active registration at the end of the study 
were included, so past activity for patients 
who registered during the study period was 
included under their latest practice, even 
where it occurred in a non-TPP practice. 
A very small number of patients may 
have overlapping registrations, meaning 
any activity they had will be counted 
against multiple practices. Patients who 
died or de-registered from TPP practices 
throughout the study period were not 
included. Overall, activity counts were up 
to 6%–8% lower than database totals in the 
earliest months of the study period. 
Comparison with existing literature
A recent systematic review of healthcare 
usage during the pandemic, encompassing 
81 studies across 20 countries, found 
that healthcare utilisation reduced 
by approximately one-third during 
the pandemic.11 This is in line with the 
findings in the current study of substantial 
reductions in April and May. However, 
by using near real-time data it was also 
possible to detect ongoing recovery. 
WHO also found significant disruption to 
countries’ healthcare capacity for NCDs 
in May5 and highlighted the importance 
that countries ‘build back better’ healthcare 
services for people with NCD, partially as 
they are more likely to experience adverse 
outcomes from COVID-19.7 
Some studies have been conducted in 
the UK CPRD that covers 13% of the UK 
population. One such study found a rate 
reduction of 0.77 for haemoglobin A1c testing 
among people with type 2 diabetes in England 
in March 2020 and a similar reduction in new 
type 2 diabetes diagnoses compared with 
10-year averages;12 there was some recovery 
in the following months, but not reaching the 
normal range until December 2020. Another 
CPRD study found substantial reductions 
in primary care contacts for acute physical 
and mental conditions such as depression, 
self-harm, diabetic emergencies, and 
COPD/asthma exacerbations, with ‘limited 
recovery’ by July 2020;13 similarly this current 
study found recovery had occurred in a broad 
range of coded activity by September. In a 
separate article this current author group 
found there was no drop-off in INR activity 
after adjustment for the amount of people on 
warfarin, the medicine that requires routine 
‘H3’ — Chronic obstructive lung disease
(Practices included: 2.5k [99.8%]; 2020 events: 0.26m); 2020 patients: 205.0k
February median: 1.1 (IDR 2.7), April median: 0.5 (IDR 2.2), September median: 0.7 (IDR 2.1)
Change in median from 2019: April –49.0% (Small drop); September –35.7% (Small drop);
Overall classification: Sustained drop


















Chronic obstructive lung disease
Acute exacerbation of chronic obstructive airway
Bronchiectasis
Emphysema
























































Figure 5. Recording of codes grouped under ‘chronic 
obstructive lung disease’ across TPP practices in 
England (January 2019 to September 2020). The group 
includes CTV3 codes that begin with ‘H3’ and is not 
necessarily an exhaustive collection of every activity 
related to chronic obstructive lung disease. The top five 
codes represented within this group are listed under 
the graph. 
CTV3 = Clinical Terms Version 3. IDR = interdecile 
range. k = thousand. m = million. 
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INR monitoring.14 Some national data 
sources can also be used to assess trends 
in NHS activity, such as cancer referral and 
treatment15 and primary care prescribing.16 
However, such high-level datasets are useful 
for giving an overview of activity (and, in 
the case of prescribing data, regional/local 
breakdowns), but do not permit linkage 
to demographic or clinical features as is 
possible with patient-level records. 
a) ‘Xalet’ — Chronic obstructive pulmonary disease annual review
(Practices included: 2.5k [99.4%]; 2020 events: 0.31m); 2020 patients: 245.2k
February median: 1.7 (IDR 3.8), April median: 0.3 (IDR 2.7), September median: 0.8 (IDR 3.0)
Change in median from 2019: April –66.7% (Large drop); September –36.1% (Small drop); 
Overall classification: Sustained drop
b) ‘Xaleq’ — Asthma annual review
(Practices included: 2.5k [99.9%]; 2020 events: 1.08m); 2020 patients: 811.8k
February median: 5.1 (IDR 7.8), April median: 2.8 (IDR 10.6), September median: 3.8 (IDR 8.4)
Change in median from 2019: April –29.3% (Small drop); September –11.8% (No change); 
Overall classification: Recovered
c) ‘XaQHq’ — Asthma control test
(Practices included: 2.5k [98.7%]; 2020 events: 0.64m); 2020 patients: 354.2k
February median: 0.8 (IDR 7.4), April median: 0.4 (IDR 7.8), September median: 2.8 (IDR 10.2)










































































































































































Figure 6. Recording of selected individual codes related 
to annual reviews for long-term respiratory conditions 
across TPP practices in England (January 2019 to 
September 2020): a) chronic obstructive pulmonary 
disease annual review, b) asthma annual review, 
and (c) asthma control test. These were the most 
common codes identified for these activities, but other 
codes may also be used to record the same or similar 
activities. 
IDR = interdecile range. k = thousand. m = million. 
Ethical approval
This study was approved by the Health 
Research Authority (Research Ethics 
Committee reference: 20/LO/0651) and by the 
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Data
Access to the underlying identifiable and 
potentially re-identifiable pseudonymised 
electronic health record data is tightly 
governed by various legislative and regulatory 
frameworks, and restricted by best practice. 
The data in OpenSAFELY is drawn from 
General Practice data across England where 
TPP is the Data Processor. TPP developers 
(Chris Bates, Jonathan Cockburn, John Parry, 
Frank Hester, and Sam Harper) initiate an 
automated process to create pseudonymised 
records in the core OpenSAFELY database, 
which are copies of key structured data tables 
in the identifiable records. These are linked 
onto key external data resources that have also 
been pseudonymised via SHA-512 one-way 
hashing of NHS numbers using a shared salt. 
DataLab developers and PIs (Ben Goldacre, 
Liam Smeeth, Caroline E Morton, Seb Bacon, 
Alex J Walker, William Hulme, Helen J Curtis, 
David Evans, Peter Inglesby, Simon Davy, 
George Hickman, Krishnan Bhaskaran and 
Christopher T Rentsch) holding contracts with 
NHS England have access to the OpenSAFELY 
pseudonymised data tables as needed to 
develop the OpenSAFELY tools. These tools 
in turn enable researchers with OpenSAFELY 
Data Access Agreements to write and execute 
code for data management and data analysis 
without direct access to the underlying raw 
pseudonymised patient data, and to review 
the outputs of this code. All code for the 
full data management pipeline — from raw 
data to completed results for this analysis 
— and for the OpenSAFELY platform as a 
whole is available for review at github.com/
OpenSAFELY.
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Implications for research and practice
To the authors’ knowledge this study is both 
the first operational research output of its 
scale using NHS GP data and the first to 
take a primarily data-driven approach to 
understanding changes in general practice. 
Two broad areas for further research are 
proposed. The first area, building on this 
approach, is a programme of research 
describing the changes in healthcare 
activities across a broad range of clinical 
areas. Second, to support WHO and NHS 
England recommendations to ‘build back 
better’, it is necessary to understand the 
causes of the changes observed, for example, 
determining genuine changes in disease 
prevalence or presentation, versus changes 
in delivery of healthcare services, or changes 
in coding behaviour. As an immediate 
first step the authors have established a 
clinical advisory group comprising GPs, 
pharmacists, relevant specialists, and 
national clinical advisers with patient and 
public involvement being coordinated by the 
Association of Medical Research Charities. 
This group will review similar data to those 
published in this report on a diverse range 
of subject areas such as mental health, 
cardiovascular disease, and diabetes. The 
authors will synthesise feedback and openly 
share short written reports describing the 
findings, identifying any important signals, 
actionable insights that are suitable for 
interactive dashboard candidates, and 
research recommendations. The authors 
will then actively seek community feedback 
to iterate these reports. Ultimately, working 
closely with EHR providers, the aim is to 
present actionable data insights directly back 
to individual practices to improve patient care 
and inform response to COVID-19.
The COVID-19 pandemic has brought 
new challenges for the NHS to deliver safe 
and effective routine care. This study has 
shown sharp changes in delivery of activity 
related to clinical care with quick recovery 
observed in certain activities. Although 
some important blood tests remained 
relatively stable throughout the period, 
most pathology test activity experienced 
substantial reductions, largely recovering 
to near-normal levels by September. This 
may be an indicator of an effective general 
practice system independently responding 
in the midst of a global health emergency 
to deprioritise inessential tests at the height 
of the pandemic and quickly recovering 
as the ‘first wave’ subsided. The proposed 
NHS Service Restoration Observatory can 
support evaluation of national policies 
around service restoration and additionally 
provide opportunities for near real-time 
audit and feedback to rapidly identify and 
resolve concerns around health service 
activity. In particular, the hope is that data 
tools such as this one can be used to ensure 
continuity of high-priority clinical services 
during subsequent waves of the pandemic.
In conclusion, substantial changes in 
activity from April to September 2020 in 
healthcare service delivery as a result of 
the COVID-19 pandemic were observed. 
Although some important tests remained 
relatively stable throughout the period, 
most pathology test activity experienced 
substantial reductions, largely recovering to 
near-normal levels by September. Records 
of respiratory infections decreased with 
the exception of codes related to COVID-
19, whereas activity for other respiratory 
disease codes was mixed. The authors are 
now further developing the OpenSAFELY 
NHS Service Restoration Observatory for 
real-time monitoring and feedback, using 
primary care data to measure and rapidly 
mitigate the indirect health impact of 
COVID-19 on the NHS.
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